Dorianna Sandona

Title: Dorianna Sandona: Innovator in Sarcoglycanopathies Treatment

Introduction

Dorianna Sandona is a notable inventor based in Padua, Italy. She has made significant contributions to the field of medical research, particularly in the treatment of sarcoglycanopathies. Her innovative work has led to advancements in understanding and addressing these rare genetic disorders.

Latest Patents

Dorianna Sandona holds a patent for a combination treatment of sarcoglycanopathies. Sarcoglycanopathies are autosomal recessive diseases caused by mutations in genes coding for sarcoglycans. Her research demonstrated that small molecules, known as CFTR correctors, can improve the maturation of several α-sarcoglycan mutants. This improvement allows these mutants to be effectively rescued at the plasma membrane. The patent highlights that specific CFTR correctors can provide additive and even synergistic effects when administered in combination.

Career Highlights

Throughout her career, Dorianna Sandona has focused on innovative treatments for genetic disorders. Her work has been instrumental in advancing the understanding of sarcoglycanopathies and developing potential therapies. She has been recognized for her contributions to medical research and innovation.

Collaborations

Dorianna has collaborated with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Évry Val d'Essonne. These collaborations have enhanced her research and expanded the impact of her work in the scientific community.

Conclusion

Dorianna Sandona's innovative research in the treatment of sarcoglycanopathies showcases her dedication to advancing medical science. Her contributions have the potential to improve the lives of individuals affected by these genetic disorders.